Patent pools and standard setting in diagnostic genetics

被引：12

作者：

Ebersole, TJ ^{[1
]}

Guthrie, MC ^{[1
]}

Goldstein, JA ^{[1
]}

机构：

[1] Sterne Kessler Goldstein & Fox PLLC, Washington, DC 20005 USA

来源：

NATURE BIOTECHNOLOGY | 2005年 / 23卷 / 08期

关键词：

D O I：

10.1038/nbt0805-937

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Properly structured and implemented, diagnostic patent pools could integrate complementary technologies, reduce transaction costs and spur innovation.

引用

页码：937 / 938

页数：2

共 7 条

[1] Genes and patent policy: rethinking intellectual property rights [J].

Andrews, LB .

NATURE REVIEWS GENETICS, 2002, 3 (10) :803-808

[2] Patents, genomics, research, and diagnostics [J].

Barton, JH .

ACADEMIC MEDICINE, 2002, 77 (12) :1339-1347

[3] Why the gene patenting controversy persists [J].

Eisenberg, RS .

ACADEMIC MEDICINE, 2002, 77 (12) :1381-1387

[4]

Goldstein J., 2005, DRUG DISCOV WORL SPR, P87

[5] Cystic fibrosis population carrier screening: Here at last-Are we ready? [J].

Grody, WW ;

Desnick, RJ .

GENETICS IN MEDICINE, 2001, 3 (02) :87-90

[6]

Merz JF, 1999, CLIN CHEM, V45, P324

[7]

U. S. Department of Justice (and Federal Trade Commission), 1995, ANT GUID LIC INT PRO

← 1 →